Waters Corporation, a leader in measurement instruments, is known for its diverse applications in healthcare and scientific research. The stock has shown a steady performance with robust returns on equity and assets, although its valuation ratios suggest it may not be undervalued at the moment. Investors should weigh these fundamentals while considering the broader technical indicators.
The fundamental rating provides insight into Waters Corporation's financial health and operational efficiency. The company's robust ROE and ROA reflect strong utilization of assets and equity.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 3 | |
| Return On Equity | 5 | |
| Return On Assets | 5 | |
| Debt To Equity | 2 | |
| Price To Earnings | 1 | |
| Price To Book | 1 |
The historical ratings provide a track record of the company's performance and valuations over time, highlighting sustainability in fundamentals.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-03-05 | 3 | 3 | 5 | 5 | 2 | 1 | 1 |
| Previous | 0 | 3 | 5 | 5 | 2 | 1 | 1 |
Analyst price targets provide a consensus view on potential stock advance or decline based on market analysis.
| High | Low | Median | Consensus |
|---|---|---|---|
| 480 | 350 | 395 | 401 |
The analyst sentiment reveals the current market disposition towards Waters Corporation, enabling investors to gauge market confidence.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 10 | |
| Hold | 21 | |
| Sell | 3 | |
| Strong Sell | 0 |
Waters Corporation exhibits strong fundamental attributes, notably in ROE and ROA. However, its valuation metrics like P/E and P/B suggest cautious optimism. The stock's analyst consensus of 'Hold' and its wide price target range indicate uncertainty amongst analysts. Potential investors should consider these factors alongside macroeconomic conditions. The firm’s technological edge in niche markets remains a significant opportunity driver.